Skip to main content
Equibles

NATIONS FINANCIAL GROUP INC, /IA/ /ADV

Position in ANIX — Anixa Biosciences Inc

CIK 1109767 CEDAR RAPIDS, IA
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$63,000
+$4,950 QoQ
Shares Held
22,500
0.0% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 62 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NATIONS FINANCIAL GROUP INC, /IA/ /ADV holds $4,144,884 across 10 Biotechnology names. ANIX ranks #9 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,445 $2,207,964
2 HALO
Halozyme Therapeutics, Inc.
 15,442 $1,208,645
3 VRDN
Viridian Therapeutics, Inc.\DE
 11,272 $207,066
4 PGEN
Precigen, Inc.
 16,524 $94,186
5 SGMT
Sagimet Biosciences Inc.
 12,000 $92,760
6 VNDA
Vanda Pharmaceuticals Inc.
 14,000 $85,680
7 IMRX
Immuneering Corp
 17,000 $84,830
8 MNKD
Mannkind Corp
 15,451 $65,821

All Filings in ANIX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $63,000 22,500
2026-03-31 $58,050 22,500
2025-12-31 $70,200 22,500
2025-09-30 $74,250 22,500
2025-06-30 $74,250 22,500
2025-03-31 $64,350 22,500
2024-12-31 $52,200 22,500
2024-09-30 $70,875 22,500
2024-06-30 $49,725 22,500
2024-03-31 $46,800 15,000
2023-12-31 $58,200 15,000
2023-09-30 $49,050 15,000
2023-06-30 $48,000 15,000
2023-03-31 $49,450 11,500
2022-12-31 $55,250 13,000